Bloomberg the Company

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

Serb Galenika Says It Secures Certificate for Drug Sales in EU

Don't Miss Out —
Follow us on:

June 13 (Bloomberg) -- Galenika AD, Serbia’s state-owned drugmaker, said it received a compliance certificate for non-sterile products that allows their sales in the European Union.

Painkillers, anti-coagulants, anti-anxiety and diabetes drugs, exported so far to non-EU neighbors and Russia, will also be offered in Asia and Africa, following the approval by regulator in EU member Slovenia, the company said in an e-mailed statement.

To contact the reporter on this story: Misha Savic in Belgrade at

To contact the editor responsible for this story: James M. Gomez at

Please upgrade your Browser

Your browser is out-of-date. Please download one of these excellent browsers:

Chrome, Firefox, Safari, Opera or Internet Explorer.